- Home
- ENVB vs ALCE Comparison
ENVB vs ALCE Comparison
Compare ENVB & ALCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- ALCE
- Stock Information
- Founded
- ENVB 1994
- ALCE 2019
- Country
- ENVB United States
- ALCE United States
- Employees
- ENVB N/A
- ALCE N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- ALCE Power Generation
- Sector
- ENVB Health Care
- ALCE Utilities
- Exchange
- ENVB Nasdaq
- ALCE Nasdaq
- Market Cap
- ENVB 4.2M
- ALCE 3.7M
- IPO Year
- ENVB N/A
- ALCE N/A
- Fundamental
- Price
- ENVB $0.33
- ALCE $0.80
- Analyst Decision
- ENVB Strong Buy
- ALCE
- Analyst Count
- ENVB 1
- ALCE 0
- Target Price
- ENVB $10.00
- ALCE N/A
- AVG Volume (30 Days)
- ENVB 156.7K
- ALCE 674.0K
- Earning Date
- ENVB 11-14-2024
- ALCE 11-19-2024
- Dividend Yield
- ENVB N/A
- ALCE N/A
- EPS Growth
- ENVB N/A
- ALCE N/A
- EPS
- ENVB N/A
- ALCE N/A
- Revenue
- ENVB N/A
- ALCE N/A
- Revenue This Year
- ENVB N/A
- ALCE N/A
- Revenue Next Year
- ENVB N/A
- ALCE N/A
- P/E Ratio
- ENVB N/A
- ALCE N/A
- Revenue Growth
- ENVB N/A
- ALCE N/A
- 52 Week Low
- ENVB $0.30
- ALCE $0.74
- 52 Week High
- ENVB $2.92
- ALCE $162.75
- Technical
- Relative Strength Index (RSI)
- ENVB 40.19
- ALCE 22.06
- Support Level
- ENVB $0.34
- ALCE $0.98
- Resistance Level
- ENVB $0.37
- ALCE $1.23
- Average True Range (ATR)
- ENVB 0.03
- ALCE 0.11
- MACD
- ENVB 0.01
- ALCE 0.02
- Stochastic Oscillator
- ENVB 53.66
- ALCE 4.29
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.
About ALCE Alternus Clean Energy Inc.
Alternus Clean Energy Inc is an international independent clean energy producer. It develops, installs, owns and operates a diverse portfolio of utility-scale solar photovoltaic power stations (PV parks) in Europe and the USA as a long-term owner. The solar parks benefit from long-term government offtake contracts and/or Power Purchase Agreements (PPAs) with investment grade off-takers, plus energy sales to local power grids. It has approximately 8 operating parks, a total of 44 MWp in operation.